Atypical Hemolytic Uremic Syndrome: A Nationwide Colombian Pediatric Series

Objectives. Atypical hemolytic uremic syndrome (aHUS) is a rare complement-mediated kidney disease with genetic predisposition and represents up to 10% of pediatric hemolytic uremic syndrome (HUS) cases. Few studies have evaluated aHUS in Latin American population. We studied a Colombian pediatric c...

Full description

Autores:
Espitaleta, Zilac
Domínguez-Vargas, Alex
Villamizar-Martínez, Johanna
Carrascal-Guzmán, Martha
Guerrero-Tinoco, Gustavo
Pinto-Bernal, Claudia
González-Chaparro, Luz
Rojas-Rosas, Luisa
Amado-Niño, Pilar
Castillo-Arteaga, Mariángel
Alvarez-Gómez, Yeferson
Arguello-Muñoz, Laura
Morales-Camacho, William
León-Guerra, Oscar
Egea, Eduardo
Galeano-Rodríguez, Ricardo
Quintero-Gómez, Ana
Aroca-Martínez, Gustavo
Musso, Carlos G.
Tipo de recurso:
Fecha de publicación:
2024
Institución:
Universidad Simón Bolívar
Repositorio:
Repositorio Digital USB
Idioma:
eng
OAI Identifier:
oai:bonga.unisimon.edu.co:20.500.12442/14129
Acceso en línea:
https://hdl.handle.net/20.500.12442/14129
https://doi.org/10.1177/2333794X241231133
https://journals.sagepub.com/doi/10.1177/2333794X241231133
Palabra clave:
Pediatric atypical hemolytic uremic syndrome
Thrombotic microangiopathy
Extrarenal manifestations
Rights
openAccess
License
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Description
Summary:Objectives. Atypical hemolytic uremic syndrome (aHUS) is a rare complement-mediated kidney disease with genetic predisposition and represents up to 10% of pediatric hemolytic uremic syndrome (HUS) cases. Few studies have evaluated aHUS in Latin American population. We studied a Colombian pediatric cohort to delineate disease presentation and outcomes. Methods. A multicenter cohort of 27 Colombian children with aHUS were included. Patients were grouped by age at onset. Clinical features were compared using analysis of variance (ANOVA) and Fisher exact tests. Renal biopsy was performed on 6 patients who were suspected of having other renal diseases before aHUS diagnosis. Results. Most patients were male (70%). The onset of aHUS occurred frequently before age 4 years (60%) and followed gastroenteritis as the main triggering event (52%). Age groups showed comparable clinical presentation, disease severity, treatment, and outcomes. Pulmonary involvement (67%) was the main extrarenal manifestation, particularly in the 1 to 7 age group (P = .01). Renal biopsies were as follows: 3 had membranoproliferative glomerulonephritis (MPGN) type I, one MPGN type III, one C3-glomerulonephritis, and one rapidly progressive GN. Genetic screening was available in 6 patients and identified 2xCFHR5, 2xMCP, 1xADAMTS13/ THBD, and 1xDGKE mutations. A total of 15 relapses were seen, of which 8 (72%) occurred in the 1 to 7 age group. The renal outcome was not significantly different regardless of age group. Conclusion. In our cohort, we observed a relatively high frequency of extrarenal involvement at first presentation represented by pulmonary manifestations. The renal prognosis at initial presentation was worse than in previous reports.